Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bombardier, Toronto-Dominion, Valeant: Canadian Equity Preview

Don't Miss Out —
Follow us on:

Dec. 2 (Bloomberg) -- Shares of the following companies may have unusual moves in Canadian trading.

Bombardier Inc. (BBD/B CT): The world’s third-biggest civil-aircraft manufacturer is scheduled to release third-quarter earnings at 6 a.m. in Montreal. Analysts estimate the company will report profit of 9 cents a share, excluding certain items, according to the average of 19 forecasts in a Bloomberg survey.

Enbridge Inc. (ENB CT): Canada’s largest pipeline company raised its quarterly dividend by 15 percent to 49 cents a share as of the dividend payable on March 1.

Toronto-Dominion Bank (TD CT): The country’s second-biggest bank is scheduled to release fourth-quarter financial results at 6:30 a.m. in Toronto. The average profit estimate among 16 analysts in a Bloomberg survey is C$1.46 a share, excluding certain items.

Valeant Pharmaceuticals International Inc. (VRX CT): Canada’s largest drugmaker said the U.S. Food and Drug Administration declined to approve ezogabine, an epilepsy medicine developed with GlaxoSmithKline Plc, in its current form. The companies said they believe the FDA’s concerns can be addressed.

To contact the reporter on this story; Matt Walcoff in Toronto at mwalcoff1@bloomberg.net

To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.